Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.
Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.
Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
Articles from the journal Anti-Cancer Agents in Medicinal Chemistry, Volume 16 Issue 10:
- Editorial (Thematic Issue Role of Heteroaromatics as Anticancer Agents)
- Flavonoids with Therapeutic Potential in Prostate Cancer
- Inhibitors of Cancer Stem Cells
- Diazenyl Derivatives and their Complexes as Anticancer Agents
- Synthesis of Diflunisal Thiazolidinones as Anticancer Agents
- Targeting the Folate Receptor: Effects of Conjugating Folic Acid to DOX Loaded Polymeric Micelles
- Investigation of Fucoidan-Oleic Acid Conjugate for Delivery of Curcumin and Paclitaxel
- Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
- 1,3,4-Thiadiazole Based Anticancer Agents
- Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents
- Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
- Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery
For details on the articles, please visit this link :: http://bit.ly/2csjwnB